US Patent Issued to GUANGZHOU BIO-GENE TECHNOLOGY on Oct. 6 for "Anti-Claudin18.2 antigen-binding fragment or antibody, and use thereof18255119" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,972, issued on Oct. 6, was assigned to GUANGZHOU BIO-GENE TECHNOLOGY Co. LTD (Guangdong, China).

"Anti-Claudin18.2 antigen-binding fragment or antibody, and use thereof18255119" was invented by Min Luo (Guangdong, China), Guangchao Li (Guangdong, China), Wen Ding (Guangdong, China), Zhao Zhou (Guangdong, China) and Xuejun Wang (Guangdong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are an anti-Claudin 18.2 antigen-binding fragment or antibody, and the use thereof. CDR3 of a heavy chain variable region of the antigen-binding fragment comprises an amino acid sequence shown in SEQ ID NO. 3. CDR3 of a light chain variable region of the ...